EOS Technology Investment Syndicate

ILC Therapeutics is a biotechnology company developing novel peptide therapeutics to modulate the innate immune system. Its focus includes treating cancer, atopic dermatitis, psoriasis, and more recently, COVID-19.

Chromacity Ltd., founded in 2013, specializes in developing, manufacturing, and distributing wavelength tunable femtosecond lasers. Its products cater to life-sciences, spectroscopy, and engineering applications, serving customers globally. The company offers a range of lasers including Spark series for near-infrared wavelengths, Spark-OPO for tunable mid-infrared pulses, and custom OEM solutions optimized for specific applications.

ILC Therapeutics is a biotechnology company developing novel peptide therapeutics to modulate the innate immune system. Its focus includes treating cancer, atopic dermatitis, psoriasis, and more recently, COVID-19.

Novosound Ltd, founded in 2016 and based in Edinburgh, United Kingdom, specializes in the design and manufacture of innovative ultrasound sensors that address the limitations of traditional technology. As the first spin-out from the University of the West of Scotland, Novosound employs groundbreaking thin-film manufacturing techniques to create highly customizable and scalable ultrasound solutions. The company’s products are utilized across various sectors, including aerospace, oil and gas, industrial applications, as well as in medical, veterinary, and dental fields. By developing advanced imaging sensors, systems, and software, Novosound enhances high-resolution ultrasound imaging, thereby providing clients with improved capabilities in non-destructive testing and diagnostics.

ENOUGH is a company that develops and commercializes patented technology for producing mycoprotein, a meat-free food product. Its innovative process integrates production within existing bio-refineries, creating a sustainable and efficient system that produces Food, Fuel, and Feed simultaneously.

ENOUGH is a company that develops and commercializes patented technology for producing mycoprotein, a meat-free food product. Its innovative process integrates production within existing bio-refineries, creating a sustainable and efficient system that produces Food, Fuel, and Feed simultaneously.

Alfacyte Ltd. develops an immunoregulatory formulation for the oral treatment of food allergies based on the immunological activities of two candidate cytokines, with adjuvant-like activities. Its immunoregulatory combination therapy is used for the oral treatment of peanut allergy.

Xelect provides biotechnology genetics services for the aquaculture industry, supporting clients across the global seafood supply chain. It offers genotyping, pedigree reconstruction, gene expression analysis, sex determination, triploidy validation, and related genetic services to help clients meet the rising consumer demand for seafood.

Findie Development Limited, established in 2015 and based in London, United Kingdom, operates an online platform dedicated to discovering and streaming high-quality cinematic videos and short films from around the globe. The company curates a diverse collection of creative content, which is organized through a proprietary content engine that tailors recommendations to users based on their viewing preferences and interests. By bringing together a wide array of cinematic experiences in one accessible location, Findie aims to enhance the way audiences engage with film and video storytelling.

Digital Sports Arena (dba Gameday Live) is a BAFTA award winning team of game industry executives with a proven track record of delivering multi-million pound selling sports franchises. They have over a decade of experience in creating critically acclaimed and commercially successful sports management simulations. They set up Digital Sports Arena because they wanted to deliver a completely new gaming experience for fans of the genre. An experience which they think will change the landscape of sports simulation and head to head competition.